AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AI-powered ECG software wins recognition as hyperkalemia detection gains momentum
MedTech Breakthrough named an AI-powered hyperkalemia detection tool the best new ECG technology solution, signaling growing interest in using routine cardiac signals to detect metabolic risk. The recognition reflects a broader trend: AI is extending the value of existing diagnostics rather than replacing them.
FDA Clears Rapid Medical’s Latest Tigertriever, Extending the Neurovascular Device Race
Rapid Medical has earned FDA clearance for its latest Tigertriever device, adding momentum to a crowded neurovascular device market. The clearance reinforces how incremental engineering improvements can still matter a great deal in time-sensitive stroke care.
FDA Clears a New Transseptal Puncture Device, Targeting a High-Stakes Cardiology Procedure
Protaryx Medical has secured FDA clearance for a transseptal puncture device used in a highly specialized cardiac procedure. The approval matters because devices that reduce procedural complexity can influence both safety and how quickly minimally invasive cardiology techniques spread.
FDA Clears Protaryx’s Transseptal Puncture Device, Adding Momentum in Structural Heart
Protaryx has won FDA clearance for a transseptal puncture device, a procedural tool that could matter in structural heart interventions. While not as headline-grabbing as AI, this approval reflects steady innovation in core cardiovascular tooling.
FDA Clears Anumana’s ECG-AI Tool to Flag Cardiac Amyloidosis From Routine ECGs
The FDA has cleared Anumana’s ECG-AI algorithm for detecting cardiac amyloidosis, a difficult-to-diagnose condition that often hides in plain sight on standard electrocardiograms. The move expands AI’s role from workflow support into earlier disease detection, where subtle patterns can change referral and treatment timelines.
TRiCares Wins FDA IDE for Pivotal Trial of Tricuspid Regurgitation Device
TRiCares has received FDA approval to begin an investigational device exemption pivotal trial for its tricuspid regurgitation treatment. The move brings another structural-heart therapy closer to the evidence base needed for commercialization and reimbursement.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.